Meropenem Sandoz (Meropenem Trihydrate)

Meropenem, the active ingredient in Meropenem Sandoz, is a carbapenem antibiotic presented as an injection solution for intravenous use. It treats severe bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, nosocomial pneumonia, septicemia and meningitis in hospitalized patients.

GNH USA supplies Meropenem Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Meropenem is a carbapenem antibiotic used to treat serious bacterial infections.

- Complicated intra‑abdominal infections: provides rapid bacterial clearance in severe abdominal sepsis. - Complicated urinary tract infections: eradicates resistant uropathogens causing pyelonephritis. - Nosocomial pneumonia: effective against multidrug‑resistant respiratory pathogens. - Septicemia: delivers bactericidal activity in bloodstream infections. - Meningitis: penetrates the cerebrospinal fluid to treat bacterial meningitis.

Adverse reactions may occur with any antibiotic therapy.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: may be watery and self‑limiting. - Headache: transient and usually resolves without intervention. - Injection site pain: localized discomfort at the infusion site. - Rash: mild erythematous skin eruption. - Elevated liver enzymes: transient increase in hepatic transaminases.

Serious or Rare Side Effects: - Seizures: especially in patients with renal impairment or high doses. - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Clostridioides difficile‑associated diarrhea: can lead to colitis. - Neutropenia or thrombocytopenia: significant drops in white blood cells or platelets. - Renal toxicity: worsening kidney function in susceptible individuals. - Stevens‑Johnson syndrome: rare severe skin reaction.

Careful assessment is required before initiating therapy. - Renal function: adjust dose in patients with impaired renal clearance. - Allergy history: avoid in individuals with known hypersensitivity to carbapenems or other β‑lactams. - Seizure risk: monitor patients with central nervous system disorders or receiving high doses. - Pregnancy and lactation: use only when the potential benefit justifies the potential risk. - Drug interactions: review concomitant medications that may affect renal clearance. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropenem may interact with several agents that affect renal function or neurotoxicity.

Major Interactions (Avoid): - Valproic acid: increased serum levels may lead to toxicity. - Cisplatin: additive nephrotoxic effects. - Other carbapenems: concurrent use can increase overlapping toxicity.

Moderate Interactions (Monitor Closely): - Loop diuretics: heightened risk of renal impairment. - Aminoglycosides: monitor renal function and serum drug levels. - Probenecid: may reduce renal clearance of meropenem.